Literature DB >> 9737664

Expression, characterization, processing and immunogenicity of an insulin-dependent diabetes mellitus autoantigen, IA-2, in Sf-9 cells.

H Xie1, Y J Deng, A L Notkins, M S Lan.   

Abstract

Autoantibodies to a 64-kD protein and a 40-kD tryptic fragment from pancreatic islets have been detected at high frequency in the sera of patients with insulin-dependent diabetes mellitus (IDDM). IA-2, a newly isolated transmembrane protein tyrosine phosphatase, is a major islet cell autoantigen in IDDM and the precursor of a 40-kD tryptic fragment. To express large quantities of recombinant IA-2 protein and analyse post-translational modifications we expressed full-length human IA-2 in baculovirus-infected Sf-9 cells. IA-2 expression was analysed by Western blot and by immunoprecipitation of 35S-methionine-radiolabelled proteins with rabbit antisera or IDDM sera. A 120-kD IA-2 protein was detected during the early, but not the late, phase of the infection. Pulse-chase experiments showed that the 120-kD protein was processed into fragments of 64 kD and smaller fragments of approximately 50 kD, 38 kD and 32 kD. The 64-kD fragment appeared as a doublet. Tunicamycin and PNGase F treatment down-shifted the 120-kD protein and the 64-kD doublet into lower molecular weight bands, suggesting that both were glycosylated. Trypsin treatment converted the 120-kD protein and the 64-kD doublet into a 40-kD fragment. Baculovirus-expressed IA-2 was as sensitive or slightly more sensitive than in vitro translated IA-2 in detecting autoantibodies to IA-2: 66% of sera from newly diagnosed IDDM patients reacted with baculovirus-expressed IA-2 compared with 59% of the same sera which reacted with in vitro translated IA-2. It is concluded that baculovirus-expressed IA-2 is a good source of autoantigen and that a number of lower molecular weight fragments with which IDDM autoantibodies react are derived from the 120-kD full-length IA-2 molecule.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9737664      PMCID: PMC1905060          DOI: 10.1046/j.1365-2249.1998.00676.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  32 in total

1.  Autoantibodies to IA-2 in IDDM: location of major antigenic determinants.

Authors:  B Zhang; M S Lan; A L Notkins
Journal:  Diabetes       Date:  1997-01       Impact factor: 9.461

Review 2.  Sorting and processing of secretory proteins.

Authors:  P A Halban; J C Irminger
Journal:  Biochem J       Date:  1994-04-01       Impact factor: 3.857

Review 3.  The pathogenesis of insulin-dependent diabetes mellitus.

Authors:  M A Atkinson; N K Maclaren
Journal:  N Engl J Med       Date:  1994-11-24       Impact factor: 91.245

4.  Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins.

Authors:  S Baekkeskov; J H Nielsen; B Marner; T Bilde; J Ludvigsson; A Lernmark
Journal:  Nature       Date:  1982-07-08       Impact factor: 49.962

5.  Biochemical analysis of the N-glycosylation pathway in baculovirus-infected lepidopteran insect cells.

Authors:  D L Jarvis; E E Finn
Journal:  Virology       Date:  1995-10-01       Impact factor: 3.616

6.  Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma.

Authors:  M S Lan; J Lu; Y Goto; A L Notkins
Journal:  DNA Cell Biol       Date:  1994-05       Impact factor: 3.311

7.  Antibodies to islet 37k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity.

Authors:  M R Christie; S Genovese; D Cassidy; E Bosi; T J Brown; M Lai; E Bonifacio; G F Bottazzo
Journal:  Diabetes       Date:  1994-10       Impact factor: 9.461

8.  Isolation, sequence and expression of a novel mouse brain cDNA, mIA-2, and its relatedness to members of the protein tyrosine phosphatase family.

Authors:  J Lu; A L Notkins; M S Lan
Journal:  Biochem Biophys Res Commun       Date:  1994-10-28       Impact factor: 3.575

9.  Relationship of the 37,000- and 40,000-M(r) tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512).

Authors:  M A Payton; C J Hawkes; M R Christie
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

10.  The 37/40-kilodalton autoantigen in insulin-dependent diabetes mellitus is the putative tyrosine phosphatase IA-2.

Authors:  N Passini; J D Larigan; S Genovese; E Appella; F Sinigaglia; L Rogge
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

View more
  5 in total

Review 1.  Structural genomics of protein phosphatases.

Authors:  Steven C Almo; Jeffrey B Bonanno; J Michael Sauder; Spencer Emtage; Teresa P Dilorenzo; Vladimir Malashkevich; Steven R Wasserman; S Swaminathan; Subramaniam Eswaramoorthy; Rakhi Agarwal; Desigan Kumaran; Mahendra Madegowda; Sugadev Ragumani; Yury Patskovsky; Johnjeff Alvarado; Udupi A Ramagopal; Joana Faber-Barata; Mark R Chance; Andrej Sali; Andras Fiser; Zhong-yin Zhang; David S Lawrence; Stephen K Burley
Journal:  J Struct Funct Genomics       Date:  2007-12-05

2.  The dense core transmembrane vesicle protein IA-2 is a regulator of vesicle number and insulin secretion.

Authors:  Shin-ichi Harashima; Anne Clark; Michael R Christie; Abner Louis Notkins
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-06       Impact factor: 11.205

3.  IA-2 modulates dopamine secretion in PC12 cells.

Authors:  Takuya Nishimura; Shin-Ichi Harashima; Hu Yafang; Abner Louis Notkins
Journal:  Mol Cell Endocrinol       Date:  2009-09-30       Impact factor: 4.102

Review 4.  A new ELISA for dermatomyositis autoantibodies: rapid introduction of autoantigen cDNA to recombinant assays for autoantibody measurement.

Authors:  Yoshinao Muro; Kazumitsu Sugiura; Masashi Akiyama
Journal:  Clin Dev Immunol       Date:  2013-12-12

5.  Small cell lung cancer growth is inhibited by miR-342 through its effect of the target gene IA-2.

Authors:  Huanyu Xu; Tao Cai; Gilberto N Carmona; Liron Abuhatzira; Abner L Notkins
Journal:  J Transl Med       Date:  2016-09-26       Impact factor: 5.531

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.